Vistagen reports Phase 2 repeat dose results for fasedienol in SAD

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/8/2026

1. TTD
2. ABNB
3. NET
4. TEAM
5. FROG
6. DV
7. TWLO
8. CART
9. SPY
10. LYFT

Go back to Vistagen reports Phase 2 repeat dose results for fasedienol in SAD
(NASDAQ: VTGN) Delayed: 0.29 +0.01 (3.57%)
Previous Close $0.28    52 Week High $4.60 
Open $0.29    52 Week Low $2.81 
Day High $0.31    P/E N/A 
Day Low $0.28    EPS $0.00 
Volume 2,555,764